Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gloria Reeves, MD
University of Maryland
Principal Investigator - Linmarie Sikich, MD
University of North Carolina, Division of Child and Adolescent Psychiatry
Principal Investigator - Mark A. Riddle, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- University of Maryland
Baltimore, Maryland, United States
- the Zucker Hillside Hospital
Glen Oaks, New York, United States
- University of North Carolina, Division of Child and Adolescent Psychiatry
Chapel Hill, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2009
- Primary completion
- 31 Mar 2014
- Completion
- 31 Mar 2014
- Last update posted
- 25 Apr 2017
- Registered enrollment
- 127
- Registry id
- NCT00806234
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.